Does Medicare reimbursement drive up drug launch prices?
Year of publication: |
2020
|
---|---|
Authors: | Ridley, David B. ; Lee, Chung-Ying |
Published in: |
The review of economics and statistics. - Cambridge, Mass. : MIT Press, ISSN 0034-6535, ZDB-ID 207962-8. - Vol. 102.2020, 5, p. 980-993
|
Subject: | Gesetzliche Krankenversicherung | Public health insurance | Rückzahlung | Repayment | Arzneimittel | Pharmaceuticals | Preis | Price | USA | United States | 1999-2010 |
-
Perverse reverse price competition : average wholesale prices and Medicaid pharmaceutical spending
Alpert, Abby, (2013)
-
Perverse reverse price competition : average wholesale prices and medicaid pharmaceutical spending
Alpert, Abby, (2013)
-
Perverse incentives in the medicare prescription drug benefit
McAdams, David, (2006)
- More ...
-
Pricing strategy and moral hazard : copay coupons in pharmaceuticals
Lee, Chung-Ying, (2020)
-
Essays in industrial organization
Lee, Chung-ying, (2014)
-
Distance decreases with differentiation : strategic agglomeration by retailers
Picone, Gabriel A., (2009)
- More ...